| Revenue growth | Q2 revenue +8% YoY to ₹686 Cr; H1 down 2%. |
|---|---|
| Margins | Gross margin 33.7% vs 34.5% in Q2; H1 32.7% vs 31.7%; EBITDA 13.5%. |
| Demand visibility | Weak season from El Nino; channel visibility only 15-20%. |
| Management confidence | Upbeat tone; hedges on volume, margin and recovery timelines. |
Growth
Q2 revenue +8% YoY (₹686 Cr vs ₹637 Cr); H1 -2%. Volume -6-7%, value +4-5% via premium mix.
Outlook
Kairos brand turnover target ₹125 Cr this fiscal. Sotanala formulation start targeted April; may slip 1-2 months.
Risks
Volume decline; lukewarm Kairos response; OET launch delayed; working capital days up to 158 from 151.
Last quarter's promises, checked
Delivered
- Positive sales growth from Q2 → Q2 revenue +8% YoY to ₹686 Cr (= BEAT)
Partly delivered
- Sotanala formulation start Apr–May 2027 → targeted April, may slip 1–2 months (= PARTIAL)
- Q2 profit recovery over Q1 (EBITDA 11.1%) → EBITDA 13.5%; gross margin 33.7% vs 34.5% YoY (= PARTIAL)
Missed
- Substantial working-capital improvement this quarter → WC days 158 vs 151 (= MISS)
- 30+ launches in 2 yrs → 3–5 launches planned next fiscal (= MISS)
Earnings Call Transcript filed with BSE, NSE: INSECTICID. Summary written with AI assistance from the document.
Insecticides (India) Ltd: key numbers
- Share price
- ₹545.00
- Market cap
- ₹1,586 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 13.0×Sector 28.2×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Investor Presentation: Key Takeaways
Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.
Insecticides (India) Results Update
Insecticides (India) released a press release on Q2 and H1 FY27 results. Revenue grew in Q2 while profit after tax declined over the half-year.
Insecticides (India) Dividend
Insecticides (India) declared an interim dividend of Rs.5 per equity share on 5 November 2026 for 2026-2027. Record date is 12 November 2026 and payment is proposed by 17 November 2026.
- Execution
- 2026-2027
Insecticides (India) Q2 FY27 Results: Net Profit ₹56.2 Cr, Down 4.9% YoY
Insecticides (India) Ltd reported revenue from operations of ₹686.3 Cr (+7.6% YoY) and net profit of ₹56.2 Cr (-4.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.2 Cr · -4.9% YoY
Insecticides (India) Board Meeting Date
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.
Insecticides (India) Other Announcement
Insecticides (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure.